Cargando…

Effects of Treatment of Uterine Cervical Carcinoma Monitored by Magnetic Resonance Imaging - Sarajevo Experience

GOAL: The goal of this study was the determination of the effects in treatment of early stage (<IIB) and locally advanced stages (≥IIB) of uterine cervical carcinoma by using MRI. MATERIAL AND METHODS: The study was a prospective, comparative, analytical, and observational and included 74 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Sofic, Amela, Husic-Selimovic, Azra, Beslic, Nermina, Rasic, Azra, Begic, Dzenana, Tomic-Cica, Anja, Imsirevic, Nejira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AVICENA, d.o.o., Sarajevo 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402375/
https://www.ncbi.nlm.nih.gov/pubmed/28484296
http://dx.doi.org/10.5455/aim.2017.25.39-43
_version_ 1783231220329480192
author Sofic, Amela
Husic-Selimovic, Azra
Beslic, Nermina
Rasic, Azra
Begic, Dzenana
Tomic-Cica, Anja
Imsirevic, Nejira
author_facet Sofic, Amela
Husic-Selimovic, Azra
Beslic, Nermina
Rasic, Azra
Begic, Dzenana
Tomic-Cica, Anja
Imsirevic, Nejira
author_sort Sofic, Amela
collection PubMed
description GOAL: The goal of this study was the determination of the effects in treatment of early stage (<IIB) and locally advanced stages (≥IIB) of uterine cervical carcinoma by using MRI. MATERIAL AND METHODS: The study was a prospective, comparative, analytical, and observational and included 74 patients with cervical cancer (PH confirmed). All 74 patients have initially gone through the pre-therapeutic MRI to determine the tumour FIGO stage. At a renewal of the initial MRI findings, patients were divided into two study groups: group A and group B. Group A consisted from 39 patients with early-stage cervical carcinoma (<IIB) and group B comprised from 35 patients with locally advanced stage (≥IIB). Postterapeutic MRI control, were perfomed in both group (A and B). Further MRI examinations were set for the patients from both groups. RESULTS: An analysis of treatment outcomes in group A showed that most patients had no local recurrence or residuum disease in 89.7%, while local recurrence was observed in only 10.3% cases. An analysis of treatment outcomes in group B showed that most patients had complete regression after local chemoradiotherapy in 68.8%, while 25.7% of patients had local progression of the disease, while the 5.7% cases recorded partial local tumour regression(p<0.05). It has been shown that a complete local regression was more frequent in the case of squamous cell carcinoma in 74.2% vs 25% in adenocarcinoma cases. Also local and partial regression was observed more frequently in the case of squamous cell carcinoma in 6.5% compared to 0% in adenocarcinoma, while progression was more common in adenocarcinoma at 75% compared to 19.4% for squamous cell (p<0.05). MRI results showed positive outcome of treatment group A and B in our study, showed a statistically significant difference in favour of group A (89.7%) compared to group B 68.8% (p<0.05). CONCLUSION: The results obtained from our studies show that early stage cervical cancer (<IIB) shows a better outcome in treatment of advanced stages (≥IIB). In the treatment of advanced stages (≥IIB), concomitant radio chemotherapy shows significant results in terms of complete tumour regression, especially in squamous cell type of cervical cancer.
format Online
Article
Text
id pubmed-5402375
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher AVICENA, d.o.o., Sarajevo
record_format MEDLINE/PubMed
spelling pubmed-54023752017-05-08 Effects of Treatment of Uterine Cervical Carcinoma Monitored by Magnetic Resonance Imaging - Sarajevo Experience Sofic, Amela Husic-Selimovic, Azra Beslic, Nermina Rasic, Azra Begic, Dzenana Tomic-Cica, Anja Imsirevic, Nejira Acta Inform Med Original Paper GOAL: The goal of this study was the determination of the effects in treatment of early stage (<IIB) and locally advanced stages (≥IIB) of uterine cervical carcinoma by using MRI. MATERIAL AND METHODS: The study was a prospective, comparative, analytical, and observational and included 74 patients with cervical cancer (PH confirmed). All 74 patients have initially gone through the pre-therapeutic MRI to determine the tumour FIGO stage. At a renewal of the initial MRI findings, patients were divided into two study groups: group A and group B. Group A consisted from 39 patients with early-stage cervical carcinoma (<IIB) and group B comprised from 35 patients with locally advanced stage (≥IIB). Postterapeutic MRI control, were perfomed in both group (A and B). Further MRI examinations were set for the patients from both groups. RESULTS: An analysis of treatment outcomes in group A showed that most patients had no local recurrence or residuum disease in 89.7%, while local recurrence was observed in only 10.3% cases. An analysis of treatment outcomes in group B showed that most patients had complete regression after local chemoradiotherapy in 68.8%, while 25.7% of patients had local progression of the disease, while the 5.7% cases recorded partial local tumour regression(p<0.05). It has been shown that a complete local regression was more frequent in the case of squamous cell carcinoma in 74.2% vs 25% in adenocarcinoma cases. Also local and partial regression was observed more frequently in the case of squamous cell carcinoma in 6.5% compared to 0% in adenocarcinoma, while progression was more common in adenocarcinoma at 75% compared to 19.4% for squamous cell (p<0.05). MRI results showed positive outcome of treatment group A and B in our study, showed a statistically significant difference in favour of group A (89.7%) compared to group B 68.8% (p<0.05). CONCLUSION: The results obtained from our studies show that early stage cervical cancer (<IIB) shows a better outcome in treatment of advanced stages (≥IIB). In the treatment of advanced stages (≥IIB), concomitant radio chemotherapy shows significant results in terms of complete tumour regression, especially in squamous cell type of cervical cancer. AVICENA, d.o.o., Sarajevo 2017-03 /pmc/articles/PMC5402375/ /pubmed/28484296 http://dx.doi.org/10.5455/aim.2017.25.39-43 Text en Copyright: © 2017 Amela Sofic, Azra Husic-Selimovic, Nermina Beslic, Azra Rasic, Dzenana Begic, Anja Tomic-Cica, Nejira Imsirevic http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Paper
Sofic, Amela
Husic-Selimovic, Azra
Beslic, Nermina
Rasic, Azra
Begic, Dzenana
Tomic-Cica, Anja
Imsirevic, Nejira
Effects of Treatment of Uterine Cervical Carcinoma Monitored by Magnetic Resonance Imaging - Sarajevo Experience
title Effects of Treatment of Uterine Cervical Carcinoma Monitored by Magnetic Resonance Imaging - Sarajevo Experience
title_full Effects of Treatment of Uterine Cervical Carcinoma Monitored by Magnetic Resonance Imaging - Sarajevo Experience
title_fullStr Effects of Treatment of Uterine Cervical Carcinoma Monitored by Magnetic Resonance Imaging - Sarajevo Experience
title_full_unstemmed Effects of Treatment of Uterine Cervical Carcinoma Monitored by Magnetic Resonance Imaging - Sarajevo Experience
title_short Effects of Treatment of Uterine Cervical Carcinoma Monitored by Magnetic Resonance Imaging - Sarajevo Experience
title_sort effects of treatment of uterine cervical carcinoma monitored by magnetic resonance imaging - sarajevo experience
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402375/
https://www.ncbi.nlm.nih.gov/pubmed/28484296
http://dx.doi.org/10.5455/aim.2017.25.39-43
work_keys_str_mv AT soficamela effectsoftreatmentofuterinecervicalcarcinomamonitoredbymagneticresonanceimagingsarajevoexperience
AT husicselimovicazra effectsoftreatmentofuterinecervicalcarcinomamonitoredbymagneticresonanceimagingsarajevoexperience
AT beslicnermina effectsoftreatmentofuterinecervicalcarcinomamonitoredbymagneticresonanceimagingsarajevoexperience
AT rasicazra effectsoftreatmentofuterinecervicalcarcinomamonitoredbymagneticresonanceimagingsarajevoexperience
AT begicdzenana effectsoftreatmentofuterinecervicalcarcinomamonitoredbymagneticresonanceimagingsarajevoexperience
AT tomiccicaanja effectsoftreatmentofuterinecervicalcarcinomamonitoredbymagneticresonanceimagingsarajevoexperience
AT imsirevicnejira effectsoftreatmentofuterinecervicalcarcinomamonitoredbymagneticresonanceimagingsarajevoexperience